- Home
- LCNB vs SLDB Comparison
LCNB vs SLDB Comparison
Compare LCNB & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCNB
- SLDB
- Stock Information
- Founded
- LCNB 1877
- SLDB 2013
- Country
- LCNB United States
- SLDB United States
- Employees
- LCNB N/A
- SLDB N/A
- Industry
- LCNB Major Banks
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LCNB Finance
- SLDB Health Care
- Exchange
- LCNB Nasdaq
- SLDB Nasdaq
- Market Cap
- LCNB 206.8M
- SLDB 234.8M
- IPO Year
- LCNB N/A
- SLDB 2018
- Fundamental
- Price
- LCNB $15.38
- SLDB $5.28
- Analyst Decision
- LCNB
- SLDB Strong Buy
- Analyst Count
- LCNB 0
- SLDB 10
- Target Price
- LCNB N/A
- SLDB $15.10
- AVG Volume (30 Days)
- LCNB 25.1K
- SLDB 1.7M
- Earning Date
- LCNB 07-22-2025
- SLDB 08-12-2025
- Dividend Yield
- LCNB 5.70%
- SLDB N/A
- EPS Growth
- LCNB 31.98
- SLDB N/A
- EPS
- LCNB 1.14
- SLDB N/A
- Revenue
- LCNB $82,862,000.00
- SLDB N/A
- Revenue This Year
- LCNB N/A
- SLDB N/A
- Revenue Next Year
- LCNB $6.72
- SLDB N/A
- P/E Ratio
- LCNB $13.48
- SLDB N/A
- Revenue Growth
- LCNB 18.71
- SLDB N/A
- 52 Week Low
- LCNB $13.24
- SLDB $2.41
- 52 Week High
- LCNB $17.92
- SLDB $10.37
- Technical
- Relative Strength Index (RSI)
- LCNB 58.89
- SLDB 65.14
- Support Level
- LCNB $14.85
- SLDB $4.76
- Resistance Level
- LCNB $15.49
- SLDB $5.70
- Average True Range (ATR)
- LCNB 0.36
- SLDB 0.38
- MACD
- LCNB 0.09
- SLDB 0.02
- Stochastic Oscillator
- LCNB 87.50
- SLDB 78.63
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.